| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman of the Board | Executive Chairman of Board | Chairman and CEO +1 more
1 company
Stanley T Crooke last filed a Form 4 in January 2021, as Executive Chairman of the Board at IONS. From January 2019 to January 2021, the filings on record show 0 open-market purchases and 17 sales. Stanley T Crooke's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 2,021 shares of IONS. The IONS filings lean toward selling, a net 516,628 shares.
Shares as reported in the last Form 4 for each company; the most recent is from January 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2020 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sell | 16,000 | $45.16 | $722,546.00 | -70.9% | |
| Mar 17, 2020 | IONS Ionis Pharmaceuticals Inc | Executive Chairman of the Board | Sell | 20,390 | $44.75 | $912,355.00 | -22.2% | |
| Aug 21, 2019 | IONS Ionis Pharmaceuticals Inc | Chairman and CEO | Sale+OE | 22,000 | $71.52 | $1,573,500.00 | -24.0% | |
| Jul 18, 2019 | IONS Ionis Pharmaceuticals Inc | Chairman & CEO | Sale+OE | 10,000 | $70.25 | $702,506.00 | -12.6% | |
| Apr 16, 2019 | IONS Ionis Pharmaceuticals Inc | Chairman and CEO | Sale+OE | 32,000 | $84.84 | $2,714,999.84 | -85.3% | |
| Feb 26, 2019 | IONS Ionis Pharmaceuticals Inc | Chairman and CEO | Sale+OE | 77,000 | $60.77 | $4,679,498.70 | -52.5% | |
| Feb 13, 2019 | IONS Ionis Pharmaceuticals Inc | Chairman and CEO | Sale+OE | 46,904 | $60.09 | $2,818,268.00 | -89.4% |